BRILINTA 90MG TABLET (Ticagrelor 90mg) Heart Care Guide
BRILINTA 90MG TABLET contains Ticagrelor 90mg, an antiplatelet medicine prescribed to help prevent harmful blood clot formation and reduce the risk of cardiovascular events in eligible patients.
BRILINTA 90MG TABLET
BRILINTA 90MG TABLET (Ticagrelor 90mg): Comprehensive Guide and Benefits
Introduction to BRILINTA 90MG TABLET (Ticagrelor 90mg)
BRILINTA 90MG TABLET: A P2Y12 Platelet Inhibitor (Antiplatelet Medicine)
BRILINTA 90MG TABLET is a prescription cardiovascular medicine containing Ticagrelor 90mg. It belongs to the drug class Antiplatelet Agents (P2Y12 Platelet Receptor Inhibitors) and is used to reduce the formation of harmful blood clots in patients with certain heart-related conditions, including acute coronary syndromes and those who have undergone coronary procedures when prescribed by a cardiologist. (National Drug Formulary)
BRILINTA 90MG TABLET works by preventing platelets from becoming activated and sticking together, thereby reducing the chance of clot formation inside blood vessels. Ticagrelor is often prescribed along with low-dose aspirin as part of dual antiplatelet therapy in appropriate patients. This medicine should only be taken under medical supervision due to its effect on bleeding risk and cardiovascular health. (1mg)
Key Benefits of BRILINTA 90MG TABLET (Ticagrelor 90mg)
Helps reduce platelet aggregation and blood clot formation.
Supports prevention of cardiovascular events in eligible patients.
Helps reduce the risk of clot-related complications after certain heart procedures.
Provides rapid and reversible P2Y12 platelet inhibition.
Supports long-term cardiovascular protection when prescribed appropriately.
How BRILINTA 90MG TABLET (Ticagrelor 90mg) Works
BRILINTA 90MG TABLET contains Ticagrelor, a direct-acting and reversible P2Y12 adenosine diphosphate (ADP) receptor antagonist. It blocks ADP-mediated platelet activation by preventing signalling through the P2Y12 receptor, which reduces platelet aggregation and decreases the formation of arterial blood clots. This mechanism helps lower thrombotic risk in patients with cardiovascular conditions requiring antiplatelet therapy. (Drugs.com)
Usage Instructions for BRILINTA 90MG TABLET (Ticagrelor 90mg)
Take BRILINTA 90MG TABLET exactly as prescribed by your cardiologist or healthcare provider.
Swallow the tablet whole with water; do not alter the dose without medical advice.
Take the medicine at the same time each day for consistent antiplatelet activity.
Attend regular medical follow-ups to monitor heart health and treatment response.
Do not stop the medicine suddenly unless advised by your doctor, as clotting risk may increase.
Medicinal Advantages of BRILINTA 90MG TABLET (Ticagrelor 90mg)
Provides effective platelet inhibition through P2Y12 receptor blockade.
Helps prevent clot-related cardiovascular complications in high-risk patients.
Supports management of acute coronary syndrome under specialist care.
Helps maintain protection after certain coronary interventions.
Offers an oral antiplatelet treatment option for eligible patients.
NOTE: BRILINTA 90MG TABLET is a prescription-only medicine. It should be used under medical supervision. Doctors may evaluate bleeding risk, heart condition, liver function, and other medicines before and during treatment. (National Drug Formulary)
Off-Label Uses of BRILINTA 90MG TABLET (Ticagrelor 90mg)
Ticagrelor may occasionally be considered for uses outside approved indications based on specialist assessment and available clinical evidence.
Specialist-guided management of selected vascular conditions.
Physician-directed antiplatelet strategies in specific clinical situations.
Individualised cardiovascular treatment approaches.
Disclaimer: Off-label uses should only occur under physician supervision and may not be approved in all countries.
Expert Advice for Optimal Use
Take BRILINTA 90MG TABLET regularly as prescribed.
Inform healthcare providers before surgeries or dental procedures.
Report unusual bleeding or prolonged bleeding episodes to your doctor.
Avoid missing doses unless instructed by your healthcare provider.
Inform your doctor about all medicines, supplements, and herbal products.
Maintain recommended heart-healthy lifestyle habits alongside treatment.
Precautions
Cardiovascular Health
Patients with a history of heart disease, recent heart attack, stroke, or coronary procedures should use BRILINTA only under cardiologist supervision. Regular cardiovascular assessment may be required.
Liver & Kidney Function
Patients with liver disease should inform their doctor before use. Kidney function evaluation may be considered based on overall health status.
Pregnancy & Breastfeeding
Pregnant or breastfeeding women should use BRILINTA 90MG TABLET only after consultation with a healthcare professional to assess potential benefits and risks.
Drug Interactions
Inform your doctor about all medicines being taken, especially anticoagulants, other antiplatelet medicines, strong CYP3A inhibitors or inducers, and medicines affecting bleeding risk.
Existing Medical Conditions
Patients with active bleeding, bleeding disorders, previous intracranial bleeding, or upcoming surgery should inform their doctor before starting treatment.
Storage Instructions
Store below 30°C in a dry place.
Keep tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep away from children.
Do not use after the expiry date mentioned on the pack.
Frequently Asked Questions (FAQs)
Q: What is BRILINTA 90MG TABLET used for?
A: BRILINTA 90MG TABLET is used to reduce blood clot formation and help prevent cardiovascular complications in eligible patients with certain heart conditions. (1mg)
Q: What is the active ingredient in BRILINTA 90MG TABLET?
A: The active ingredient is Ticagrelor 90mg. (National Drug Formulary)
Q: What type of medicine is BRILINTA 90MG TABLET?
A: It is an antiplatelet medicine belonging to the P2Y12 platelet receptor inhibitor class.
Q: How does BRILINTA 90MG TABLET work?
A: It blocks P2Y12 receptors on platelets, reducing platelet activation and preventing excessive clot formation. (Drugs.com)
Q: Can BRILINTA 90MG TABLET be stopped suddenly?
A: No. Stopping treatment without medical advice may increase the risk of clot-related cardiovascular events.
Q: Is BRILINTA 90MG TABLET taken with aspirin?
A: In many clinical situations, doctors prescribe Ticagrelor along with aspirin as part of dual antiplatelet therapy, depending on the patient’s condition. (1mg)
Q: Who should consult a doctor before taking BRILINTA 90MG TABLET?
A: Patients with bleeding disorders, liver problems, upcoming surgery, or those taking blood-thinning medicines should consult their doctor before use.
Product Tags
BRILINTA 90MG TABLET, BRILINTA TABLET, Ticagrelor 90mg, Ticagrelor tablet, antiplatelet medicine, P2Y12 inhibitor, blood thinner tablet, cardiovascular medicine, heart attack prevention medicine, stroke prevention medicine, acute coronary syndrome treatment, AstraZeneca Brilinta, prescription heart medicine, platelet inhibitor tablet, cardiology medicine, coronary artery disease medicine, heart care tablet, thrombus prevention medicine, cardiac therapy, oral antiplatelet drug.
